9:31AM ET 1/15/2021 MT NewswiresNextCure (NXTC) has an average rating of outperform and price targets ranging from $11 to $32, according to analysts polled by Capital IQ. (MT Newswires...
4:11PM ET 1/14/2021 MT NewswiresNextCure (NXTC) said after markets closed Thursday that it has appointed Dr. Han Myint as chief medical officer. Dr. Myint has more than two decades of...
10:46AM ET 7/16/2020 MT NewswiresNextCure (NXTC) has an average hold rating among analysts, with an average price target of $33. (MT Newswires covers equity, commodity and economic...
9:27AM ET 7/14/2020 MT NewswiresNextCure (NXTC) has an average hold rating among analysts, with an average price target of $37. (MT Newswires covers equity, commodity and economic...